InfuSystem Holdings INFU
NYSE INFU
$12.21 +0.01 (+0.08%)
At close: Aug 21, 2026 · 4:00 PM EDT

InfuSystem Holdings (INFU) Cash from Investing Activities (2010 - 2026)

InfuSystem Holdings' (INFU) quarterly Cash from Investing Activities came in at -$1.3 million in Q1 2026, up 52.65% YoY from -$825421.0 in Q1 2025, and up 42.52% on a QoQ basis from -$2.2 million in Q4 2025.

InfuSystem Holdings (INFU) Cash from Investing Activities (2010 - 2026) Analysis & Trends

InfuSystem Holdings (INFU) has 17 years of Cash from Investing Activities data on file, last reported at -$1.3 million in Q1 2026.

  • Quarterly Cash from Investing Activities rose 52.65% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (up 65.19% YoY) and the FY2025 annual result came in at -$6.8 million, up 48.71% from the prior year.
  • Cash from Investing Activities improved to -$1.3 million in Q1 2026, from -$2.2 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$252000.0 in Q3 2025 to a low of -$6.7 million in Q2 2024.
  • A 5-year average of -$2.3 million and a median of -$2.3 million in 2023 frame the typical range for Cash from Investing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 91.43% — and 2024, when it slumped 852.0%.
  • Tracing INFU's Cash from Investing Activities over 5 years: stood at -$3.1 million in 2022, then surged by 65.79% to -$1.0 million in 2023, then tumbled by 213.12% to -$3.3 million in 2024, then surged by 32.95% to -$2.2 million in 2025, then jumped by 42.52% to -$1.3 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$1.3 million (Q1 2026), -$2.2 million (Q4 2025), and -$252000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -673.00 Mn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -639.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -917.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -1.96 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -193.20 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 329.80 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -115.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -22.08 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -108.50 Mn
10 InfuSystem Holdings 244.87 Mn 243.90 Mn 21.41 Mn -4.52 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.52 Mn
Jun 30, 2026 -4.52 Mn
Mar 31, 2026 -1.26 Mn
Mar 31, 2026 -1.26 Mn
Dec 31, 2025 -2.19 Mn
Dec 31, 2025 -2.19 Mn
Sep 30, 2025 -252,000.00
Sep 30, 2025 -252,000.00
Jun 30, 2025 -1.69 Mn
Jun 30, 2025 -1.69 Mn
Mar 31, 2025 -2.66 Mn
Mar 31, 2025 -2.66 Mn
Dec 31, 2024 -3.27 Mn
Dec 31, 2024 -3.27 Mn
Sep 30, 2024 -2.86 Mn
Sep 30, 2024 -2.86 Mn
Jun 30, 2024 -6.70 Mn
Jun 30, 2024 -6.70 Mn
Mar 31, 2024 -418,000.00
Mar 31, 2024 -418,000.00